US Patent RE48751 Immunoconjugates with an intracellularly-cleavable linkage
Patent RE48751 was granted and assigned to IMMUNOMEDICS, INC. on September, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent RE48751 Immunoconjugates with an intracellularly-cleavable linkage
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
